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Purpose: Our aim was to generate and phenotypically characterize a transgenic mouse line expressing a constitutively
active variant of the transcription regulatory protein serum response factor (SRF), namely the SRF-VP16 protein. This
new mouse strain has been registered under the designation Gt(ROSA)26Sortm1(SRF-VP16)Antu. We found phenotypic changes
upon ectopic expression of SRF-VP16, especially in the mouse retina.
Methods: Using homologous recombination, we integrated an SRF-VP16 conditional (i.e., “flox-STOP” repressed)
expression transgene into the Rosa26 locus of murine embryonic stem (ES) cells. These engineered ES cells were used
to  derive  the  Gt(ROSA)26Sortm1(SRF-VP16)Antu  mouse  strain.  Semiquantitative  real-time  PCR  was  used  to  determine
expression of the SRF-VP16 transgene at the mRNA Oevel, EothLn\oungP20Dnd330)DndDdultsixPonths
old) Gt(ROSA)26Sortm1(SRF-VP16)Antu mice. We also investigated the transcript levels of endogenous Srf and several SRF
target  genes.  Retinal  function  was  tested  by  electroretinography  in  both  young  and  adult  mice.  Morphological
abnormalities could be visualized by hematoxylin and eosin staining of sectioned, paraffin-embedded eye tissue samples.
Scanning-laser ophthalmoscopy was used to investigate retinal vascularization and degeneration in adult mice.
Results: We show that the SRF-VP16 mRNA is expressed to a low but significant degree in the retinas of young and adult
animals of the Gt(ROSA)26Sortm1(SRF-VP16)Antu mouse strain, even in the absence of Cre-mediated deletion of the “flox-
STOP” cassette. In the retinas of these transgenic mice, endogenous Srf displays elevated transcript levels. Ectopic retinal
expression of constitutively active SRF-VP16 is correlated with the malfunction of retinal neurons in both heterozygous
and homozygous animals of both age groups (P20 and adult). Additionally, mislamination of retinal cell layers and cellular
rosette formations are found in retinas of both heterozygous and homozygous animals of young age. In homozygous
individuals, however, the cellular rosettes are more widespread over the fundus. At adult age, retinas both from animals
that are heterozygous and homozygous for the floxSTOP/SRF-VP16 transgene display severe degeneration, mainly of the
photoreceptor cell layer. Wild-type age-matched littermates, however, do not show any degeneration. The severity of the
observed effects correlates with dosage of the transgene.
Conclusions: This is the first report suggesting an influence of the transcription factor SRF on the development and
function of the murine retina. Ectopic SRF-VP16 mRNA expression in the retinas of young animals is correlated with
photoreceptor layer mislamination and impaired retinal function. At an advanced age of six months, degenerative processes
are detected in SRF-VP16 transgenic retinas accompanied by impaired retinal function. The Gt(ROSA)26Sortm1(SRF-
VP16)Antu mouse strain represents a genetic SRF gain-of-function mouse model that will complement the current SRF loss-
of-function models. It promises to provide new insight into the hitherto poorly defined role of SRF in retinal development
and function, including potential contributions to ophthalmologic disorders. Furthermore, using conditional Cre-mediated
activation of SRF-VP16, the described mouse strain will enable assessment of the impact of dysregulated SRF activity
on the physiologic functions of various other organs.
In the mouse eye, the retina is composed of various cell
types that are strictly organized into distinct cellular layers,
all descending from the primitive central nervous system. The
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structural organization of photoreceptor cells, interneurons,
and ganglion cells into these layers is completed postnatally.
In  addition  to  cell  differentiation,  this  lamination  process
includes  neuronal  migration,  neurite  outgrowth,  axonal
guidance, and synaptic targeting [1-3]. Previous reports have
shown that the ubiquitously expressed transcription factor
serum response factor (SRF) plays an important role in all of
these processes [4-8].
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1110SRF binds CC(AT)6GG DNA sequences (called CArG-
boxes), found near promoter regions of SRF target genes [9,
10]. The SRF target genes c-fos,junB, and Egr-1 belong to the
immediate early gene family and the Srf gene itself has CArG-
boxes in its promoter region [11-14]. SRF is an important
regulator of the actin cytoskeleton, driving transcription of the
Actb and Vcl genes, among others [15-17]. The SRF-mediated
effects on the actin cytoskeleton have been studied in both
murine embryonic stem (ES) cells and in mice with different
tissue-specific conditional Srf deletions [18].
Deletion  of  full  length  SRF  in  ES  cells  results  in
impairment of actin stress fiber formation and focal adhesion
assembly  [7].  The  observed  defects  can  be  rescued  by
transfection of a construct expressing a constitutively active
variant  of  SRF,  SRF-VP16.  This  fusion  protein  has  been
reported to drive transcription of Srf target genes in vitro, and
the compensatory effect of SRF-VP16 is stronger in cells
depleted of endogenous Srf than in ES cells still expressing
endogenous  Srf  [7,19].  Interestingly,  neurons  expressing
endogenous wild-type SRF show an increase in the expression
of SRF target genes upon additional ectopic expression of
SRF-VP16 [20].
Conditional  deletion  of  Srf  in  neurons  of  the  murine
forebrain revealed a crucial role of SRF in neuronal migration,
neurite outgrowth, and axonal guidance. Impairment in the
outgrowth activity of SRF-depleted neurons in vitro could be
overcome by treatment with SRF-VP16 [6]. The same study
also showed the requirement of properly functioning SRF for
correct axonal targeting in the brain. Neuronal SRF depletion
in vivo resulted in an aberrant circuit assembly within the
hippocampus due to misguided mossy fibers [6].
Further investigations of the neuron-specific ablation of
SRF  showed  the  importance  of  SRF  for  cell  autonomous
neuronal migration. Neurons depleted of SRF in vivo fail to
migrate along the rostral migratory stream to the olfactory
bulb.  Instead,  SRF-depleted  neurons  accumulate  in  the
subventricular zone [4].
To further complement our studies of SRF function in
vivo,  we  generated  a  mouse  line  permitting  the  in  vivo
expression of the constitutively active SRF-VP16 protein. For
this purpose, we engineered a transgenic mouse carrying a
genomic  integration  of  a  floxSTOP/SRF-VP16  sequence
within the genomic ROSA26 locus. This transgene should
allow  for  the  Cre-mediated,  conditional  expression  of  the
SRF-VP16fusion  proteinXnder Wranscriptional FRQWURO
ofWheHndogenous5OSA26JeneSromoter. :eKere
present  an  initial  characterization  of  the
Gt(ROSA)26Sortm1(SRF-VP16)Antu  mouse  line.  We  demonstrate
that this line displays an ectopic expression of SRF-VP16 in
the eye, resulting in a pronounced retinal phenotype. This
effect  was  observed  in  the  absence  of  Cre-mediated
recombination, due to transcriptional “leakiness” of the STOP
cassette.  Upon  ectopic  SRF-VP16  retinal  expression,  P20
animals displayed retinal mislamination and cellular rosette
formation  in  both  heterozygous  and  homozygous  retinas.
Adult  animals  with  ectopic  retinal  SRF-VP16  expression
showed  degeneration  of  the  retina;  in  particular,  the
photoreceptor  cell  layer  was  affected.  Furthermore,  these
defects displayed dependence on dosage of the transgene, as
seen at both ages and in severity regarding the disturbance of
retinal function, retinal cellular rosette formation, and retinal
degeneration.
This is the first study to suggest a correlation between
dysregulated SRF activity and malformations of the postnatal
retina.  The  mouse  model  presented  here  offers  a
complementary  genetic  approach  to  the  existing  SRF
knockout systems, and therefore may enable new insight into
the potential roles of SRF in retinal development and function.
METHODS
Generation of the Gt(ROSA)26Sortm1(SRF-VP16)Antu mouse strain:
We aimed for conditional expression of a constitutively active
variant  of  the  SRF  protein  in  mice,  in  a  temporally  and
spatially  controlled  fashion.  For  this  purpose,  a  DNA-
targeting  construct  for  genomic  integration  into  the
ubiquitously expressed ROSA26 locus was generated; this
encoded the SRF-VP16 fusion protein under the control of a
deletable STOP cassette. The human SRF coding sequence of
the  targeting  construct  was  composed  of  a  C-terminally
truncated human SRF cDNA (encoding amino acids 1–412)
which had the endogenous transactivation domain replaced by
the  transcription  activation  domain  (C-terminal  80  amino
acids) of the herpes simplex virus protein VP16, as previously
described [21]. To allow for the conditional expression of the
SRF-VP16 fusion gene, a STOP cassette composed of four
SV40  polyadenylation  signals  (SV40  polyA)  and  a
neighboring Puromycin resistance gene [22] were introduced
upstream of the SRF-VP16 coding sequence. The Puromycin
resistance  gene  was  expressed  under  the  control  of  the
phosphoglycerate  kinase  (PGK)  promoter  and  its
transcriptional direction was opposite to that of SRF-VP16. In
addition, a splice acceptor site was introduced 5′ of the STOP
cassette  and  the  SRF-VP16  sequence,  to  achieve  proper
splicing and expression of the transgene after removal of the
STOP cassette. The STOP cassette was flanked by two loxP
sites,  thereby  enabling  its  conditional  removal  upon
expression  of  active  Cre  recombinase.  We  refer  to  this
conditional  SRF-VP16  expression  construct  as  floxSTOP/
SRF-VP16.
The floxSTOP/SRF-VP16 construct was cloned into the
XbaI site of the pROSA26–1 vector [23], thereby generating
the Rosa26-floxSTOP/SRF-VP16 targeting construct (Figure
1,  upper  panel).  This  could  be  integrated  by  homologous
recombination into the genomic Rosa26 locus (Figure 1, lower
panel). Murine R1 ES129 embryonic stem cells (SVP129
background) were electroporated with the linearized targeting
vector. Following selection with puromycin, surviving ES cell
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1111clones were screened by genomic PCR for integration within
the ROSA26 locus. Genomic DNA from positive clones was
digested with EcoRI and further tested by Southern blotting
for  the  presence  of  a  10  kb  fragment  corresponding  to
transgene integration within the targeted locus (not shown)
[24]. Recombinant ES cell clones were injected into C57BL/
6 blastocysts to generate chimeras that were bred further for
germ line transmission, resulting in the Gt(ROSA)26Sortm1(SRF-
VP16)Antu  mouse  strain  (registered  under  this  name  with  the
Mouse  Genomic  Nomenclature  Committee,  Jackson
Laboratory, MGI accession number 4838411). Mice carrying
one  allele  for  Rosa26-floxSTOP/SRF-VP16  were  denoted
heterozygous (het) and animals with two Rosa26-floxSTOP/
SRF-VP16 alleles were referred to as homozygous (hom).
Wild-type mice without any rearrangement of the Rosa26
locus were denoted Rosa26 wild-type (wt). Genotypes were
determined by genomic PCR on DNA preparations from tail
biopsies  using  the  following  primers;  ROSA-fw  (5′-GGA
GGC AGG AAG CAC TTG CTC TCC-3′) and ROSA-rev (5′-
CAC CAG GTT AGC CTT TAA GCC TGC CC-3′) for the
Rosa26 wild-type locus and ROSA-fw (5′-GGA GGC AGG
AAG CAC TTG CTC TCC-3′) and PURO-rev (5′-GAA CGA
GAT  CAG  CAG  CCT  CTG  TTC  CAC-3′)  for  Rosa26-
floxSTOP/SRF-VP16. Note that the endogenous Srf locus was
unaffected by integration of the Rosa26-floxSTOP/SRFVP16
transgene into the Rosa26 locus.
Animal  housing  and  handling  was  conducted  in
accordance  with  the  Federation  of  European  Laboratory
Animal Science Associations and the local ethics committee
(Regierungspräsidium Tübingen) approved all experiments
presented in this study.
Reverse-transcription  and  semiquantitative  real-time  PCR
analysis: Total mRNA was prepared from freshly isolated
tissues of mice aged P20 to P24, as well as from six-month-
old  animals,  using  the  RNeasy  Kit  (Qiagen,  Düsseldorf,
Germany), and subsequently treated with DNaseI (Roche,
Rotkreutz, Switzerland). cDNA was synthesized from 1 μg of
total mRNA and reverse-transcription was performed (M-
MLV  Reverse  Transcriptase,  Promega,  Madison,  WA)
following the manufacturer’s instructions. One-twentieth of
the reverse transcription reaction was used for a 15 μl PCR
reaction, and real-time amplification was monitored using
Sybr®  Green  (Applied  Biosystems,  Foster  City,  CA)
technology [7]. Glyceraldehyde 3-phosphate dehydrogenase
(Gapdh) mRNA was used as internal control for each sample
and all reactions were run in triplicate. Primers GAPDH-fw
(5′-TGG ATC TGA CGT GCC GC-3′) and GAPDH-rev (5′-
TGC  CTG  CTT  CAC  CAC  CTT  C-3′)  were  used  for
GAPDH message, Srf-fw (5′-TGT GCA GGC CAT TCA TGT
G-3′)  and  Srf-rev  (5′-ACA  GAC  GAC  GTC  ATG  ATG
GTG-3′) for the 3′ part of the endogenous Srf message, and
VP16-fw (5′-CTT AGA CGG GCA AGT G-3′) and VP16-rev
(5′-CCC AAC ATG TCC AGA TCG AAA-3′) for the VP16
part of the SRF-VP16 message. Statistical significance was
calculated using the Student’s t-test and standard deviations
are presented in standard error of the mean (SEM).
Electroretinography:  Electroretinography  (ERG)
measurements were performed with P30 mice as well as six-
Figure 1. Schematic representation of the Rosa26-floxSTOP/SRF-VP16 DNA targeting construct. The Rosa26-floxSTOP/SRF-VP16 DNA
targeting construct (upper) and its integration site in the wild-type genomic Rosa26 locus (lower) are shown. Black arrows indicate EcoRI
restriction sites, applied to Southern blot detection of the targeting construct (10 kb band) and the wild-type ROSA26 locus (15 kb band), using
the probe indicated. White arrows indicate XbaI restriction sites generated upon the insertion of the floxSTOP/SRF-VP16 construct into the
ROSA26–1 vector. The black box depicted upstream of the Puro-PGK cassette represents the splice acceptor. Black triangles indicate the two
loxP sites flanking the STOP cassette.
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1112month-old mice (adult). Of the fifteen P30 mice, 5 were wild-
type, 5 were floxSTOP/SRF-VP16 (het), and 5 were floxSTOP/
SRF-VP16 (hom). Of the fourteen adult mice, 4 were wild-
type, 5 were floxSTOP/SRF-VP16 (het), and 5 were floxSTOP/
SRF-VP16 (hom).
Animals were dark-adapted over a period of at least 24 h.
They were anesthetized by an intraperitoneal injection of a
mixed  ketamine/xylazine  solution  (120  mg/kg  ketamine,
10 mg/kg xylazine). The cornea of the eye was desensitized
with  a  drop  of  Novesine  (Novartis  Ophthalmics,  Basel,
Switzerland). The upper eyelids were retracted slightly by a
surgical  silk  thread.  To  keep  body  temperature  constant,
animals were placed onto a heated platform (37 °C) during the
measurements.  Gold-wire-ring  electrodes  placed  onto  the
corneas of both eyes served as working electrodes and a gold-
wire-ring electrode placed in the mouth served as a reference
electrode. A stainless steel needle electrode was inserted into
the tail of the animals for grounding. The pupils were dilated
with  a  drop  of  tropicamide  (Novartis  Ophthalmics).  All
manipulations were performed under dim red light, which was
switched  off  after  finishing  all  the  stages  of  animal
preparation. After an additional 5 min to allow the pupils to
dilate,  measurement  was  started  using  the  commercial
RetiPort32  device  from  Roland  Consult  Systems
(Brandenburg, Germany).
Standard  ERG  measurements  were  performed,  with
scotopic flash ERG at up to eight different light intensities
from 0.0003 to 100 cd⋅s/m2, an additional run for scotopic
oscillatory potentials at 100 cd⋅s/m2, photopic 30 Hz flicker
at 3 cd⋅s/m2 after 10 min of light adaptation, photopic flash
ERG, and photopic oscillatory potentials. The light intensity
used for the flashes in the photopic ERG measurements was
100 cd⋅s/m2.
The time of measurement was 160 ms, with 512 data
points per measured waveform. The analog filters of the ERG
device were set to the frequency ranges of 0.5 to 200 Hz for
both scotopic and photopic flash ERG, 50 to 500 Hz for
oscillatory potentials, and 10 to 50 Hz for 30 Hz flicker. In
addition, the waveforms of the oscillatory potentials were
digitally  filtered  offline  using  a  digital  signal  processing
(DSP)  filter  included  in  the  software  of  the  ERG  device
(−15  dB  for  f<10  Hz).  The  amplitudes  of  a-waves  were
measured  from  the  baseline  to  the  bottom  of  the  a-wave
trough, whereas b-wave amplitudes were measured from the
bottom of the a-wave trough to the peak of the b-wave. ERG
measurements were performed simultaneously on both eyes
in each animal, and the eye giving the better parameters was
chosen for data evaluation.
Histological methods: Eyes from P20-to-P24 or six-month-
old (P180) animals were fixed for 4 h in Davidson’s fixative
(PBS; 137 mM NaCl, 2.7 mM KCl, 10mM Na2HPO4 and
2 mM KH2PO4, containing 6% formaldehyde, 32% ethanol,
11% acetic acid, and 5% sucrose) before further processing.
Histological examination of the retina was done on 4 μm
sections of paraffin-embedded eyes, mounted on Superfrost
Plus  slides  (Langenbrinck,  Emmendingen,  Germany).
Sections were stained with hematoxylin and eosin; residual
stain  was  removed  by  washing  under  running  tap  water,
followed  by  dehydration  and  mounting  in  Entellan®  Neu
(Merck KGaA, Darmstadt, Germany) under coverslips.
Scanning-laser  ophthalmoscopy:  Scanning-laser
ophthalmoscopy  (SLO)  was  performed  according  to
previously  reported  procedures  [25].  Briefly,  mice  were
anesthetized by subcutaneous injection of ketamine (66.7 mg/
kg) and xylazine (11.7 mg/kg). After anesthesia, pupils were
dilated  with  tropicamide  eye  drops  (Mydriaticum  Stulln,
Pharma  Stulln,  Stulln,  Germany).  SLO  imaging  was
performed with a Heidelberg Retina Angiograph (HRA I)
equipped with an argon laser featuring two wavelengths (488
nm  and  514  nm)  in  the  short  wavelength  range  and  two
infrared  diode  lasers  (795  nm  and  830  nm)  in  the  long
wavelength range.
The laser wavelength used for fundus visualization was
514 nm (red-free channel). The 488 nm wavelength was used
for fundus autofluorescence (FAF) analysis. Additionally, the
488 nm and 795 nm lasers were used for fluorescein (FL)
angiography  (FLA)  and  indocyanine  green  (ICG)
angiography (ICGA), respectively. FLA was performed using
a  subcutaneous  injection  of  75  mg/kg  bodyweight  FL-Na
(University  Pharmacy,  University  of  Tübingen,  Germany)
and ICGA following a subcutaneous injection of 50 mg/kg
bodyweight ICG (ICG-Pulsion, Pulsion Medical Systems AG,
Munich, Germany).
RESULTS
Generation  of  transgenic  mice  allowing  conditional
expression  of  the  constitutively  active  SRF-VP16  fusion
protein:  To  establish  a  genetic  model  for  the  study  of
phenotypic effects elicited by conditional in vivo expression
of a constitutively active variant (termed SRF-VP16) of the
transcription factor SRF, we generated a transgenic mouse
carrying an inducible SRF-VP16 transgene in its genome (for
details, see Materials and Methods). The obtained mouse line
was  named  Gt(ROSA)26Sortm1(SRF-VP16)Antu.  The  SRF-VP16
transgene was composed of the coding sequence of the human
SRF, where part of the SRF C-terminal transactivation domain
was replaced by the herpes simplex virus VP16 transcriptional
activation domain, as previously described by Dalton and
Treisman  (1992)  [21].  Upstream  of  the  SRF-VP16  fusion
cDNA, a STOP cassette was positioned; this was flanked by
two  loxP  sites  (Figure  1),  permitting  transcriptional  read-
through  upon  conditional  Cre-mediated  STOP  cassette
deletion.  This  deletion  was  achieved  by  crossing  the
Gt(ROSA)26Sortm1(SRF-VP16)Antu strain with the CamKIIα-iCre
mouse line [26] expressing Cre recombinase (data not shown).
In this report, however, we focus on the effects observed upon
Rosa26-floxSTOP/SRF-VP16  transgene  integration
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1113independent of Cre expression, since as detailed below, the
presence of the genomic STOP cassette did not fully prevent
expression of SRF-VP16. Gt(ROSA)26Sortm1(SRF-VP16)Antu mice
carrying  the  Rosa26-floxSTOP/SRF-VP16  transgene  were
born  with  the  expected  Mendelian  distribution  and  their
behavior  (gait,  feeding,  and  motor  reflexes)  was
indistinguishable from that of their wild-type littermates. We
did, however, observe a weight reduction in both hetero- and
homozygous Rosa26-floxSTOP/SRFVP16 mice of about 22%
(p=0.0546, Student t-test) as compared to Rosa26 wild-type
littermate  controls  (data  not  shown).  Despite  the  weight
reduction, genomic integration of the Rosa26-floxSTOP/SRF-
VP16 allele did not affect either lifespan or fertility of the
Gt(ROSA)26Sortm1(SRF-VP16)Antu mice.
Ectopic  retinal  expression  of  the  Rosa26-floxSTOP/SRF-
VP16 transgene: A relevant feature of transcriptional STOP
cassettes is their “transcriptional tightness,” i.e., their ability
to  efficiently  prevent  the  expression  of  the  associated
transgene. At the same time, removal of the STOP cassette
should enable efficient expression of the transgene. We tested
for  potential  “leakiness”  of  the  STOP  cassette  and
investigated mRNA expression of the SRF-VP16 transgene in
Gt(ROSA)26Sortm1(SRF-VP16)Antu  mice  using  semiquantitative
real-time PCR. Expression was investigated in samples from
the heart, liver, skeletal muscle, brain (cortex, hippocampus,
and cerebellum), lens, and retina. Interestingly, SRF-VP16
expression was found in the retina (Figure 2), while all of the
other tissues investigated were negative for SRF-VP16 mRNA
expression  (data  not  shown).  SRF-VP16  transcripts  could
already be detected in both hetero- and homozygous retinas
at day P8 at very low levels (not shown); statistical evaluation
was first possible at day P20 (Figure 2, upper left).
At the protein level, we were unable to detect SRF-VP16
protein expression by western blot analysis using anti-VP16
antisera on tissue lysates from P20-to-P24 retinas (data not
shown). This is likely due to low SRF-VP16 expression levels
and/or insufficient sensitivity of the antisera available. We
also  attempted  to  detect  the  SRF-VP16  protein  by
immunohistochemical staining on P20 specimens using anti-
VP16  antisera.  However,  no  signal  of  SRF-VP16
immunoreactivity  could  be  detected  (data  not  shown).
Endogenous SRF protein was ubiquitously expressed in all
cells of the retina, and the observed ectopic expression of SRF-
VP16  mRNA  did  not  manifest  itself  in  an  increased
immunoreactivity of endogenous SRF (data not shown).
To further characterize the expression of the Rosa26-
floxSTOP/SRF-VP16  transgene  in  the  retina,  we  analyzed
transcript levels in adult animals at the age of six months
(P180). At this age, comparable to P20, significant levels of
SRF-VP16  mRNA  were  observed  in  both  hetero-  and
homozygous  retinas  (Figure  2,  upper  right).  With  P180
animals, we also tried to address retinal SRF-VP16 protein
expression. However, as seen with the P20 retinas, western
blotting of P180 retinal extracts also failed to reveal SRF-
VP16  protein  expression  (data  not  shown).  Similarly,  the
SRF-VP16  protein  could  not  be  detected  by
immunohistochemistry (data not shown).
Since SRF is known to autoregulate transcription of its
own gene [14], we also investigated whether the SRF-VP16
transgene  influenced  the  expression  levels  of  endogenous
Srf mRNA. Indeed, we could observe a significant, 1.7 fold
elevation of Srf mRNA expression in transgenic heterozygous
and homozygous P20 retinas, as compared to wild-type retina
levels (Figure 2, lower left). In adult tissue, we observed
elevations  in  Srf  mRNA  levels  that  were  2.3  fold  in
heterozygous  and  6.7  fold  in  homozygous  retinas,  as
compared to wild-type levels (Figure 2, lower right). We also
investigated the mRNA expression levels of other known SRF
target genes, namely Bcl2, Actb, and SMA, but no significant
change in expression levels in either of these genes could be
observed (data not shown). We conclude that, in the retinal
tissue  of  Gt(ROSA)26Sortm1(SRF-VP16)Antu  mice,  the  Rosa26-
floxSTOP/SRF-VP16  transgene  is  transcribed  to  low  yet
significant  levels,  giving  rise  to  SRF-VP16  mRNA.  We
interpret this RNA product to be due to “leaky” read-through
transcription, since the presence of the nonrearranged STOP
cassette  was  confirmed  both  by  genomic  PCR  and
semiquantitative  real-time  PCR  on  genomic  DNA  (not
shown). Furthermore, the presence of SRF-VP16 message
correlated with elevated levels of endogenous Srf mRNA.
Retinal malfunction upon ectopic SRF-VP16 activation: Since
SRF-VP16  was  shown  to  affect  the  neurite  outgrowth  of
hippocampal neurons in vitro [6], we investigated potential
functional  consequences  of  retinal  SRF-VP16  mRNA
expression  in  Gt(ROSA)26Sortm1(SRF-VP16)Antu  mice.  For  this
purpose,  we  characterized  retinal  function  by  ERG
measurements. Typical ERG waveforms obtained in wild-
type P30 mice are shown in Figure 3A. The amplitudes of the
scotopic ERG a-waves and b-waves from P30 heterozygous
and homozygous mice are smaller than those of their wild-
type littermates. The corresponding values of a-wave and b-
wave amplitudes are shown in Figure 3B. The difference in
amplitude between heterozygous and homozygous mice was
not significant, whereas amplitudes obtained in homozygous
mice were significantly smaller at higher light intensities than
those obtained in wild-type mice. Amplitudes of scotopic and
photopic oscillatory potentials of P30 heterozygous mice were
similar  to  those  of  wild-type  mice,  whereas  those  of
homozygous animals were reduced (Figure 3A; quantification
in Figure 4A). The heterozygous P30 animals showed smaller
photopic b-wave and photopic 30 Hz flicker amplitudes as
compared to wild-type mice, and this reduction was even
larger in homozygous animals (Figure 3A; quantification in
Figure 4B). The ratio between the amplitudes of b-waves and
a-waves, the so-called b/a ratio, was not different in the three
strains  (Figure  4C);  in  contrast,  the  ratio  between  the
amplitudes of oscillatory potentials and b-waves, the OP/b
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1114ratio, was higher in homozygous animals than in wild-type
animals (Figure 4D).
In P180 mice, we observed clear differences in the ERG
waveforms and parameters of heterozygous and homozygous
animals  as  compared  to  wild-type  control  animals.
Furthermore, as compared to P30 animals, P180 wild-type
animals also displayed waveforms typical of normal mice, as
shown in Figure 5A. The ERG waveforms of the heterozygous
animals were mildly affected, while those of homozygous
animals were drastically affected. The scotopic a-wave and b-
wave amplitudes in the heterozygous and homozygous mice
were  significantly  smaller  than  in  the  wild-type  animals.
Moreover, the amplitudes of the homozygous animals were
also significantly smaller than those of the heterozygous mice
(Figure 5B). In addition, at this stage (P180), homozygous
animals showed significantly diminished amplitudes of both
Figure 2. Retinal mRNA levels of SRF-VP16 and endogenous Srf at ages P20 and P180. Real-time PCR quantification of relative SRF-
VP16 and endogenous Srf mRNA levels in the retinas of P20 and P180 mice. SRF-VP16 RNA levels were only observed in retinas of Rosa26-
floxSTOP/SRF-VP16 transgenic mice, both heterozygous (het) and homozygous (hom) for the SRF-VP16 transgene (upper panels). Expression
of endogenous Srf was always elevated compared to wild-type mice in the presence of the transgene; this was especially pronounced in the
transgenic P180 (hom) mice (lower panels). Error bars indicate SEM, *p<0.05, **p<0.01, and ***p<0.001, denoting significance as compared
to wild-type mice. All transcriptional levels were normalized to Gapdh.
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1115Figure 3. Graphs presenting electroretinographic measurements of animals at age P30. Electoretinographic (ERG) waveforms obtained in P30
(one-month-old) mice of the Rosa26 (wt), Rosa26-floxSTOP/SRF-VP16 (het), and Rosa26-floxSTOP/SRF-VP16 (hom) genotypes. A: Typical
waveforms are shown of scotopic and photopic ERGs, scotopic and oscillatory potentials, as well as the photopic 30 Hz flicker, as indicated.
Note the different scaling. B: Values of amplitudes of scotopic a-waves and b-waves, depending on the intensity of light stimuli. Significances
of differences between wild-type and homozygous mice are indicated by asterisks, and significances of the differences between heterozygous
and homozygous mice is indicated by crosses (* or †p<0.05, ** or ††p<0.01, ***p<0.001).
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1116Figure 4. Quantification of electroretinographic parameters. Comparison of several electroretinographic (ERG) parameters obtained in P30
and P180 Rosa26 wild-type (wt), Rosa26-floxSTOP/SRF-VP16 (het), and Rosa26-floxSTOP/SRF-VP16 (hom) mice, respectively, as indicated.
A: Scotopic- (left) and photopic (right) oscillatory index. B: Photopic b-wave (left) and photopic 30Hz flicker (right). C: b/a ratio. D: OP/b
ratio. Significances of differences between wild-type and transgenic mice are indicated by asterisks, and significances of the differences
between heterozygous and homozygous mice are indicated by crosses (* or †p<0.05, ** or ††p<0.01, ***p<0.001).
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1117scotopic and photopic oscillatory potentials as compared to
heterozygous and wild-type animals, and the amplitudes of
the heterozygous animals were also significantly reduced in
comparison to wild-type controls (Figure 4A and Figure 5A).
The reduction of photopic b-wave and photopic 30 Hz flicker
amplitudes measured in heterozygous and homozygous mice
compared to wild-type animals was even larger at P180 than
the  corresponding  reduction  at  P30,  and  again  significant
(quantification in Figure 4B). No significant difference could
be found in the b/a ratio between wild-type and heterozygous
mice at P180 (Figure 4C), whereas it was markedly decreased
in homozygous animals compared to wild-type mice (Figure
4C).  The  OP/b  ratio  was  significantly  increased  in  P180
heterozygous and homozygous animals compared to wild-
type mice (Figure 4D).
In contrast to all the differences in amplitudes shown
here, no significant differences in the latencies of a-waves, b-
waves, or oscillatory potentials could be found, although the
latencies obtained in homozygous mice had a slight tendency
to be prolonged at both investigated ages (not shown).
Photoreceptor mislamination in SRF-VP16 positive retinas:
We next investigated the morphological basis for the severe
disturbances  of  ERG  characteristics  in  hetero-  and
homozygous  transgenic  animals.  Interestingly,  upon
histological  examination,  we  observed  a  disordered
lamination in the direct circumference of the optic nerve in
both heterozygous and homozygous P20 retinas (Figure 6B,C,
arrowheads). However, in the periphery, retinal lamination
appeared  normal  in  the  eyes  of  both  heterozygous  and
homozygous  animals  (Figure  6A-C).  Larger  microscopic
magnifications  of  the  disorganized  areas  revealed  rosette
formation  in  the  photoreceptor  cell  layer  (Figures  6E,F),
where the inner and outer segments appeared encircled by
photoreceptor cell nuclei constituting the outer nuclear layer
segments.  In  some  cases,  formation  of  rosettes  in
heterozygous animals could be observed to the same extent as
in  homozygous  animals  (not  shown),  but  in  general,  the
majority of the heterozygous animals had less widespread
rosettes  compared  to  homozygous  littermates.  Statistical
evaluation  of  all  histological  sections  showed  only  a  few
heterozygous  individuals  with  normal  retinal  lamination,
comparable to those of wild-type retinas (Figure 6J). More
than 80% of the heterozygous animals showed a significant
degree of disorganization of the retinal layers (Figure 6H,J),
while all homozygous animals examined displayed extensive
formation of rosettes (Figure 6I,J). To exclude disturbances
due to changes in the number of photoreceptor cell nuclei, the
numbers of photoreceptor nuclei rows of the outer nuclear
layer were counted. We did not observe any difference in
between the wild-type animals and the hetero- or homozygous
transgenic animals (data not shown).
Retinal degeneration in adult SRF-VP16 expressing mice:
Disorganization of retinal morphology was also found in the
eyes of six-month-old (P180) heterozygous and homozygous
Gt(ROSA)26Sortm1(SRF-VP16)Antu  mice  (Figure  7).  The  most
striking finding at this stage was a clear retinal degeneration
in  the  vicinity  of  the  optic  nerves  of  heterozygous  and
homozygous transgenic animals (Figures 7B,C), compared to
retinas  of  wild-type  animals,  which  showed  normal
photoreceptor layers (Figure 7A). Little or no degeneration
was  found  in  more  peripheral  parts  of  the  retina.  The
degeneration observed in P180 animals appeared to originate
from areas equivalent to those that displayed rosette formation
in P20 mice (Figure 6). Magnification of the degenerating
areas revealed a partial degradation (eight rows or less) up to
complete absence of the photoreceptor layers in heterozygous
retinas  (Figure  7E).  In  homozygous  retinas,  sites  of
degeneration were also scattered over the posterior part of the
eye. Here, only parts of the inner nuclear layer, the inner
plexiform layer, and the retinal ganglion cell layer remained
detectable,  as  shown  in  Figure  7F.  Moreover,  the  retinal
pigment epithelium (RPE) was also disturbed at several sites.
Statistical assessment of histological sections revealed that
approximately  60%  of  the  heterozygous  animals  showed
degeneration in some regions of the retina, while more than
80%  of  the  homozygous  animals  displayed  degeneration
(Figure 7G).
SLO on six-month-old Gt(ROSA)26Sortm1(SRF-VP16)Antu mice: To
further elucidate phenotypic changes in the retinas of six-
month-old  Gt(ROSA)26Sortm1(SRF-VP16)Antu  mice  and  to
investigate whether vascular defects could be involved in the
observed  retinal  degeneration,  SLO  [25]  was  performed
(Figure 8). This analysis included native, red-free funduscopy
at a wavelength of 514 nm to display retinal vessels and the
nerve  fiber  layer  (Figure  8,  left  column).  Second,  FAF
analysis at 488 nm was applied (Figure 8, middle left column).
FAF revealed retinal vessel structures as shadows embedded
within a general diffuse “glow,” permitting the simultaneous
visualization  of  pathologically  enhanced  autofluorescence
[25]. Third, retinal and choroidal vessels were analyzed by
FLA. Whereas the large retinal vessels and capillaries can be
displayed in detail by FLA using fluorescein (FL) (Figure 8,
middle right column), both retinal and choroidal vessels can
be imaged when ICGA is applied (Figure 8, right column). In
comparison to wild-type mice (Figure 8, upper row), SLO
analysis  of  heterozygous  (middle  row)  and  homozygous
animal eyes (lower row) revealed various changes in fundus
appearance, which might be directly correlated with retinal
degenerative processes. In 514 nm funduscopic images, large
patchy areas were clearly visible in transgenic eyes (Figure 8,
left  column).  FAF  analysis  revealed  the  pathological
accumulation of autofluorescent material (likely derived from
lipofuscin-containing lipids) in these areas (Figure 8, middle
left column). In both heterozygous and homozygous animals,
angiography with either FL (Figure 8, middle right column)
or  ICG  (Figure  8,  right  column)  revealed  enhanced
pathological visibility into deeper layers of the retina. Such
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1118Figure 5. Graphs presenting electroretinographic measurements of animals at age P180. Electroretinographic (ERG) measurements obtained
with P180 (six-month-old) mice of the Rosa26 (wt), Rosa26-floxSTOP/SRF-VP16 (het), and Rosa26-floxSTOP/SRF-VP16 (hom) genotypes.
A: Typical waveforms are shown of scotopic and photopic ERGs, scotopic and oscillatory potentials, as well as the photopic 30 Hz flicker,
as indicated. Note the different scaling. B: Values of amplitudes of scotopic a-waves and b-waves depending on the intensity of light stimuli
are shown. Amplitudes measured in wild-type mice are larger than amplitudes obtained in the mutants, with high significance over almost all
light intensities (***p<0.001).
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1119sites of visibility of deeper retinal layers are not detectable in
Rosa26  wild-type  animals.  Moreover,  large  retinal  blood
vessels, as well as small capillaries, appeared to be more
disturbed in mutant mice, particularly homozygous animals.
DISCUSSION
Generation of SRF-VP16 expressing mice: In this report, we
describe  the  first  generation  of  a  mouse  line  permitting
conditional expression of a constitutively active variant of the
transcription  factor  SRF.  The  line  Gt(ROSA)26Sortm1(SRF-
VP16)Antu  carries  the  SRF-VP16  transgene  within  the
Figure 6. Rosette formations in the photoreceptor layer of P20 animals heterozygous or homozygous for the Rosa26-floxSTOP/SRF-VP16
transgene. Histological sections are provided displaying rosette formations in the photoreceptor layers of Rosa26- floxSTOP/SRF-VP16
heterozygous or homozygous P20 animals. A-C: Hematoxylin and eosin–stained sections are shown of retinas obtained from wild-type,
heterozygous, and homozygous P20 animals. Scale bar represents 200 μm. A: Normal wild-type retina is displayed and compared to those of
heterozygous (B) and homozygous (C) transgenic animals, showing the localization of rosette formation around the vicinity of the optic nerve.
D-F: Magnifications are shown of regions of the retinas displaying normal (D) or dyslaminated (E, F) retinal layers. Normal mislamination
in wild-type retinas (D) with the ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer nuclear layer (ONL),
inner and outer segments (IS/OS), and retinal pigment epithelium (RPE). Rosette formations to a varying extents are shown in heterozygous
(E) and homozygous (F) P20 retinas. Scale bars represent 50 μm. G: Quantification of rosette formation is shown. Retinas displaying rosette
formations were categorized as positive for rosette formation. Eighty-seven percent of the heterozygous animals showed rosette formation,
while 100% homozygous animals displayed rosette structures.
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1120ubiquitously  expressed  genomic  Rosa26  locus  (Figure  1).
Since transgene expression is impaired by the presence of a
“floxed” STOP cassette, the desired conditional expression of
the transgene can be activated by Cre-mediated deletion of the
STOP cassette. We have shown that the induction of SRF-
VP16 expression occurred when the above transgenic line was
bred with mice expressing the Cre recombinase cell type-
specifically in neurons of the forebrain and hepatocytes of the
liver (manuscripts in preparation). We therefore expect the
mouse line described here to provide a useful tool for a variety
of different genetic studies on SRF function.
Figure 7. Retinal degeneration in P180 mice heterozygous or homozygous for the Rosa26-floxSTOP/SRF-VP16 transgene. Histological
sections of P180 retinas are shown displaying degenerative processes in Rosa26-floxSTOP/SRF-VP16 heterozygous (het) and homozygous
(hom) animals. A-C: Hematoxylin and eosin staining. Note the scattered degeneration in the posterior part of heterozygous and homozygous
retinas. Peripheral regions show no degeneration. Scale bars represent 200 μM. D-F: Higher magnifications of P180 retinas are displayed.
Wild-type retina (D) showing ganglion cell layer, inner plexiform layer, inner nuclear layer, outer nuclear layer, inner and outer segments and
retinal pigment epithelium (RPE). Degeneration of the photoreceptor layer in adult heterozygous (E) and homozygous (F) retinas is shown.
In (F), arrowheads point to regions of complete degeneration of the inner and outer nuclear layers, whereas inner nuclear layers can be found
at least partially in other places (asterisks). Occasionally, even the ganglion cell layer can no longer be found (indicated by horizontal double-
headed arrow). Scale bars represent 50 μM. G: Quantification of individual mice displaying retinal degeneration in histological sections.
Retinas displaying areas in the outer nuclear layer with eight or fewer layers of photoreceptor nuclei were classified as having “partial retinal
degeneration.” Sixty percent of the heterozygous animals and over 80% of the homozygous animals showed partial degeneration.
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1121The current report, however, focuses on the unexpected
finding that the Rosa26-floxSTOP/SRF-VP16  transgene is
expressed selectively, at low constitutive levels, in retinal
tissue. This expression is observed in the absence of Cre-
mediated deletion of the STOP cassette. We can show in both
one- and six-month-old animals that “leaky” expression of
SRF-VP16 mRNA occurs selectively in the retina, but not in
the other tissues tested, including the heart, skeletal muscle,
brain (cortex, hippocampus, and cerebellum), and lens. The
STOP cassette used here has previously been reported to be
tight [22], although the general phenomenon of “leakiness” of
STOP cassettes has been discussed extensively [27-29]. Given
the  low  basal  levels  of  the  transgenic  transcript,  and
consequently our inability to visualize the SRF-VP16 protein,
we presently do not know which cells of the retina express the
SRF-VP16 transgene, nor can we currently pinpoint the exact
time of onset of its expression.
Phenotypic consequences of retinal SRF-VP16 expression:
Here, we describe the phenotypic changes displayed in the
eyes of the Gt(ROSA)26Sortm1(SRF-VP16)Antu mice, as observed
upon  leaky  expression  of  the  SRF-VP16  transgene  in  the
absence of Cre-mediated recombination. In P20 retinas of
hetero- and homozygous transgenic animals, we observed not
only  significant  transcript  levels  of  SRF-VP16,  but  also
Figure 8. Scanning-laser ophthalmoscopy (SLO) imaging. Eyes from Rosa26 (wt; upper row), Rosa26-floxSTOP/SRF-VP16 (het) (middle
row), and Rosa26-floxSTOP/SRF-VP16 (hom; bottom row) animals at six months of age (P180) were investigated. Fundus imaging with RF
at 514 nm excitation (left column) and autofluorescence at 488 nm laser wavelengths (middle left column) display dramatic changes in fundus
appearance, structure of the nerve fiber layer and accumulation of autofluorescent lipids in genetically modified animals compared to wild-
type animals. Retinal degenerative processes can also be inferred from enhanced angiographic deep layer (choroidal) signals using fluorescein
(middle right column) and indocyanine green (right column) angiography, as clearly detected in both heterozygous and homozygous animals.
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1122increased levels of endogenous Srf mRNA (Figure 2). Since
SRF-VP16 has previously been reported to  drive  transcript-
ion of SRF target genes [7,20,30-32], including Srf itself [14],
the increase in Srf  mRNA is consistent with our expectations.
This elevated expression of endogenous Srf   in  hetero-  and
homozygous retinas is maintained at an advanced age (six
months), in a pattern suggesting the gene dosage dependence
of the SRF-VP16 allele (Figure 2).
Ectopic retinal expression of constitutively active SRF-
VP16 is correlated with severe morphological abnormalities
of  the  retina,  including  retinal  mislamination  and  cellular
rosette formation of both heterozygous and homozygous P20
transgenic animals. SRF has previously been shown to play a
role  in  proper  neuronal  assembly  in  the  postnatal
hippocampus. The mossy fibers of SRF-depleted hippocampi
fail to segregate into their proper layers and show fiber growth
inside the pyramidal layer [6]. The disorganization of the
photoreceptor  layer  in  the  P20  hetero-  and  homozygous
animals,  shown  in  Figure  6,  indicates  that  the  SRF-VP16
transcript has an effect on the lamination of the postnatal
retina. This suggests that regulated SRF activity is not only
important for correct axonal guidance, but might also play a
role in neuronal lamination, as recently demonstrated [33].
Furthermore, SRF has been shown to play a vital role in
neuronal cellular motility, most likely due to its impact on
actin cytoskeletal dynamics [4,8]. Neurons deficient in SRF
show reduced capacity to migrate in vivo and axonal guidance
is  disturbed  in  vitro.  Furthermore,  SRF-ablated  neurons
treated  with  SRF-VP16  show  abnormal  axonal  sprouting,
displaying significantly longer protrusions compared to those
of wild-type neurons [6]. These previously reported effects of
SRF  on  neuronal  motility  and  migration  also  suggest  a
possible role for SRF regarding the correct assembly of the
neurons of the mouse retina. Whether the rosette formations
we observed in the SRF-VP16 positive retinas were due to
“overmigration”  or  to  incorrect  neuronal  guidance  is  still
unclear, and this awaits further investigations into potential
changes in cell proliferation and survival.
Another vital role of SRF regards its involvement in focal
adhesion  assembly,  since  murine  embryonic  stem  cells
ablated of SRF fail to adhere properly [7]. The same report
also suggested the importance of SRF for directed migration,
as exerted by its contribution to focal adhesion assembly. A
speculative  explanation  is  that  SRF-VP16-positive  retinal
neurons hold incorrect contacts to extracellular structures or
neighboring  cells,  and  therefore  are  unable  to  position
themselves in appropriate layers. However, since the exact
spatiotemporal  expression  pattern  of  the  SRF-VP16  read-
through  message  has  yet  to  be  determined,  we  cannot
currently distinguish between the observed rosette formation
due to SRF-VP16 expression in neurons or in other cells of
the retina.
Disturbances of retinal function upon SRF-VP16 expression:
ERG  is  a  sensitive  tool  to  detect  impairments  of  retinal
function.  Such  impairments  can  be  observed  in  many
pathological conditions before morphological or histological
signs of the disease become visible. Srf has previously been
shown  to  be  important  for  murine  neuronal  function  and
maintenance  in  vivo  [4,5,34,35].  Therefore,  we  first
performed ERG in one- and six-month-old animals to check
whether there were any effects of increased transcript levels
of SRF-VP16 on neuronal function in the retinas of young and
adult mice.
In wild-type mice, normal electroretinograms could be
recorded at both studied ages. In contrast, ERG amplitudes
were reduced in all mutant mice. The degree of reduction
varied in different animals, in clear correlation with the degree
of structural abnormalities. This was especially the case in the
heterozygous animals, as revealed by histological analysis. In
one of the one-month old heterozygous mice, ERG amplitudes
reached  normal  values,  whereas  ERG  amplitudes  were
drastically reduced in all other heterozygous mice.
No significant changes were found in the latencies of
scotopic and photopic a- and b-wave, and also not in the
latencies  of  the  oscillatory  potentials.  Possibly,  the
disturbances in the retinal structure lead only to a quantitative
decrease  of  the  retinal  function,  as  the  mechanisms  of
phototransduction and transmission of nerve signals appear to
be unaffected. The similarities in the b/a ratios between wild-
type mice and heterozygous mice indicate that the decrease of
b-wave amplitudes has its origin in a decreased input from the
photoreceptors.  Interestingly,  even  the  amplitudes  of
oscillatory  potentials  were  not  greatly  affected  in
heterozygous mice, indicating an intact neuronal circuitry in
the inner retina. This is in line with the histological findings
in the heterozygous mice, which show occasional rosettes in
the photoreceptor layer and virtually intact inner neuronal
layers.
At the age of six months, the ERG amplitudes measured
in both heterozygous and homozygous mice were drastically
reduced. As seen in the corresponding waveforms, retinal
activity was almost undetectable in homozygous mice at this
point  (Figure  5A).  Again,  latencies  were  not  affected
significantly. In contrast to the situation in one-month-old
mice,  amplitudes  of  oscillatory  potentials  were  clearly
decreased in the mutant mice, as were all other amplitudes.
Therefore, the degenerative processes appear to have also
reached the inner retina at the age of six months. Indeed,
histological inspection shows strong disturbances not only in
the photoreceptor layer, but also in the inner neuronal layers.
Although the decreased amplitudes of oscillatory potentials
show that degeneration has an effect on the inner neurons and
their  circuitry,  Müller  cells  and  bipolar  cells  seem  to  be
affected  even  more,  as  can  be  deduced  from  the  clearly
decreased  b/a  ratios  and  the  significantly  increased  OP/b
ratios in the mutant animals.
Correlation  of  retinal  dysfunction  and  cellular  rosette
formation: There are some links made in the literature as to
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1123how rosette formation might be connected to disturbed ERG
signals. One report shows that retinitis pigmentosa patients
with  photoreceptor  rosette  formations  have  nearly  extinct
ERG amplitudes [36], similar to what we observe in the adult
six-month-old     heterozygous   Gt(ROSA)26Sortm1(SRF-VP16)Antu
mice. Mears et al. [37] described another mutant  mouse line
showing  drastically  reduced  ERG  amplitudes,  where  the
neuronal retina leucine zipper protein has been deleted. Here,
homozygous  animals  also  display  widespread  rosette
formations accompanying the disturbed ERGs. In the eyes of
homozygous mice expressing SRF-VP16, ERG signals seems
to be drastically decreased in adult animals compared to one-
month-old mice. This observation has also been reported in
several other mutant mouse strains displaying photoreceptor
rosettes’ age-dependent decreases in ERG amplitudes [38]. In
the latter study, it was proposed that the formation of the
rosettes could be linked to the integrity of the outer limiting
membrane  or  the  interaction  between  photoreceptors  and
Müller  cell  microvilli.  In  the  Gt(ROSA)26Sortm1(SRF-VP16)Antu
mice, one could speculate that rosette formation contributes
to the disturbed function of the photoreceptor signaling and
that this malfunction in turn leads to the loss of photoreceptors
observed in adult mice.
Retinal degeneration in adult mice upon expression of SRF-
VP16:  Adult  retinas  of  six-month-old  (P180)  hetero-  and
homozygous transgenic SRF-VP16 animals displayed severe
degeneration. In particular, the photoreceptor cell layer was
reduced to half thickness in heterozygous and to complete
absence  in  homozygous  transgenic  mice  (Figure  7).  The
severity  of  the  observed  effects  therefore  correlated  with
transgene  dosage.  Furthermore,  in  both  types  of  P180
transgenic  animals,  a  severe  destruction  of  the  RPE  was
apparent.  These  effects  appeared  to  represent  a  stage  of
advanced progression with regard to the defects seen in P30
mice  (Figure  6).  SLO  was  applied  to  characterize  the
degenerated eyes of P180 transgenic mice within the living
animal. Fundus imaging (red-free and autofluorescence) and
angiography  (FLA  and  ICGA)  independently  gave  clear
indication  of  severe  retinal  degeneration.  Degeneration  of
photoreceptors is often accompanied by an accumulation of
autofluorescent,  retinoid-containing  debris  material  in  the
subretinal  space  [39].  The  retinoids  are  derived  from
photoreceptor outer segment breakdown products that contain
the  visual  pigment  chromophore  11-cis-retinal.
Autofluorescent debris signals were visibly scattered in the
eyes of heterozygous transgenic mice, and more dramatically
in the eyes of homozygous mice (Figure 8). This finding
corroborated the partial or complete loss of photoreceptor
layer segments observed by histological analysis (Figure 7).
In retinal angiography, the degree of visibility of choroidal
vessel  structures  decreased  with  increasing  amounts  of
melanin  in  the  RPE  choroid  interface  [25]  or,  more
importantly, with the presence of RPE cells in general.
Both  FLA  and  ICGA  revealed  enhanced  visibility  of
choroid  structures  in  heterozygous  and  homozygous
transgenic animals, in contrast to wild-type retinas (Figure 8).
In particular, this indicates an at least partial degeneration of
the RPE in transgenic mice, which results in the visibility of
the choroidal vessels. Again, RPE malstructuring and partial
loss was seen by histological inspection (Figure 7).
Finally, the lost integrity and regularity of retinal blood
vessels and capillaries are also most probably caused by the
retinal degeneration. With the advancing loss of retinal layers,
blood  vessels  and  capillaries  lose  their  stabilizing
environment and function, leading to malformed vessels with
disturbed blood flow. The degeneration we observe in the
adult retinas of hetero- and homozygous animals could occur
for several reasons. As one possibility, the degeneration in
later  stages  (six-month-old  retinas)  could  simply  be  a
secondary  effect  of  already-reduced  signaling  in  the  P20
retinal  neurons  that  display  the  rosette  formations.  The
reduction or complete absence of neuronal function could lead
to cell death. Another reason for degeneration could be the
induction  of  cell  death.  Moreover,  the  arrangement  of
photoreceptors in rosettes seen in many animals not only leads
to a hindered supply of glucose and oxygen, as well as an
impaired  homeostasis  of  the  extracellular  space,  but  also
makes it difficult to establish functioning neuronal circuits.
Previous reports have shown that SRF is not only required for
proliferation,  but  that  it  also  regulates  the  expression  of
antiapoptotic genes [40-42]. Furthermore, SRF has also been
shown to play a crucial role in the survival of postnatal cortical
neurons [43].
The SRF target gene c-fos has been reported to play a role
in light-induced apoptotic cell death. Mice lacking functional
c-Fos displayed less rod-photoreceptor loss as compared to
wild-type  littermates  [44].  Further  examination  of  retinal
function in c-fos−/− mice  using  ERG showed a reduction in
retinal sensitivity due to a 22% reduction in number of rods
and an overall lower rhodopsin content (25% reduced). The
authors  argue  that  apoptosis  is  induced  normally  by  the
bleaching  of  rhodopsin,  but  that  the  apoptotic  cascade  is
interrupted downstream of this event in c-fos−/− retinas due to
the absence of Fos protein [45]. In this study, we have not
addressed the role of c-fos; however, it is possible that the
abnormal expression of SRF-VP16 elicits an effect on c-fos
expression, thereby affecting the resistance to light-induced
damage and causing a more rapid degeneration. In fact, we do
observe this in the retinas of SRF-VP16 heterozygous and
homozygous adult (P180) mice.
We conclude that there is an apparent correlation between
the  increases  in  transcript  levels  of  both  SRF-VP16  and
endogenous Srf and retinal rosette formation and degenerative
processes in adult retinas. SRF represents a nuclear relay for
signaling exerted through actin cytoskeletal dynamics [17]. In
this  function,  SRF  greatly  impacts  actin  microfilament
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1124function and cellular behaviors directed by actin dynamics.
Accordingly, dysregulation of SRF often causes phenotypes
associated  with  impaired  actin  function  [18].  Of  interest
regarding  eye  diseases,  it  has  been  found  that  corneal
abnormalities caused by mutation of the Destrin gene, which
encodes  the  actin  depolymerizing  factor  (ADF),  could  be
rescued by SRF depletion [46,47]. This study identified an
actin-based, hierarchical functional relationship of Destrin
and Srf in the corneal epithelium. In summary, we showed that
Gt(ROSA)26Sortm1(SRF-VP16)Antu transgenic mice display ectopic
expression of SRF-VP16 and elevated levels of endogenous
Srf  in  the  retina.  This  overexpression  of  SRF  activity
correlates  with  structural  distortions  in  the  retinal  layers,
leading  to  the  degeneration  of  photoreceptors  and  other
neurons,  as  well  as  the  degeneration  of  the  RPE.  In
consequence,  a  severe  loss  of  retinal  function  could  be
demonstrated by ERG. The severity of these effects is stronger
in homozygous than in heterozygous animals, indicating a
gene dosage dependence of the phenotypic effects caused by
ectopic SRF activity. The reasons for and mechanisms of our
findings are not fully understood so far. However, the findings
suggest that SRF plays a role in retinal development and
possibly also in the maintenance of retinal function in the adult
animal. The next step in further investigation of the role of
Srf  in  the  mouse  retina  will  be  to  cross  the
Gt(ROSA)26Sortm1(SRF-VP16)Antu  mouse  strain  with  a  Cre-
expressing mouse line where Cre recombinase is driven by a
retina-specific promoter. Null mutagenesis of Srf in the retina
might provide further insight into the mechanisms by which
SRF contribute to retinal function.
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